Efficient Utilization of Korean Medical Fungal Pathogen Resource Bank for Clinical Research
10.17966/JMI.2019.24.3.69
- Author:
Jayoung KIM
1
;
Junsang OH
;
Gi Ho SUNG
;
Hyeyoung LEE
;
Ji Seon CHOI
;
Sangheun LEE
;
Minbum KIM
;
Sun Young CHOI
Author Information
1. Department of Laboratory Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University, Incheon, Korea. lmkjy7@gmail.com
- Publication Type:Review
- From:Korean Journal of Medical Mycology
2019;24(3):69-78
- CountryRepublic of Korea
- Language:English
-
Abstract:
A “pathogen resource†contains information about pathogens (e.g., bacteria, fungi, viruses, and protozoa) and microbial derivatives (e.g., DNA, RNA, plasmid, clone, and cDNA). Pathogen resources are important for their potential use in healthcare research because they contain clinical and epidemiological information that is different from microbial resources. In October 2014, the “Nagoya Protocol†on access and benefit-sharing with the Convention on Biological Diversity was enacted to restrict the movement of transboundary pathogens and protect the natural pathogen resources of each country. On July 2017, the Korean Medical Fungal Pathogen Resource Bank (KMFRB) was established to secure, discover, and develop biological resources focused on medical fungi. KMFRB has since been operating under the National Culture Collection for Pathogens of the National Institute of Health based on the Act No. 13992. This report aims to provide general information regarding KMFRB and suggest efficient ways to utilize human fungal pathogen resources for clinical research.
